Overview
| Name | REINVENT 4 · aliases: REINVENT4, REINVENT 4 |
|---|---|
| Full name | The name is a software name; the paper gives no expanded form |
| Ambiguous names (not auto-linked) | REINVENT |
| Family | Part of the REINVENT family |
| Organization | AstraZeneca Molecular AI (Discovery Sciences, R&D) |
| Organization type | Pharma |
| Country | Sweden, United Kingdom |
| Model class | Molecule generation and optimisation framework |
| Domain | Small molecules (also: Molecule generation) |
| First release | · code release Basis: First public repository release (v4.0.11) Note: The site recorded 2024-02-21, which is the journal paper and v4.1.8 date, not the first public version source |
| Other milestones | |
| Latest update | · new version Basis: v4.9 release v4.9 adds modular diversity filters, a clustering component, intrinsic rewards and a similarity scoring component, and removes deprecated settings source The most recent sourced event, not a claim that nothing changed since. |
| Status | Active · A new version was released within 12 months |
| Openness | Code: Open · Apache-2.0 Weights: Open · Apache-2.0 Code and priors are Apache-2.0, with priors hosted in a public data repository from v4.6.22 |
| Benchmarks reported | 0 counted (cited only 1) |
| Wet-lab validation | None recorded |
| Unverified fields | † training_data.a_public.detail |
| As of | 2026-11-16 |
What it does
Built on recurrent and transformer priors with reinforcement learning, driven from the command line with file-based task configuration, it covers de novo design, R-group replacement, linker design, scaffold hopping and optimisation, merging four previously separate tools into one repository. Unlike prompt-style general generators such as GenMol it needs a scoring function defined per task, and it sits opposite Saturn on the same reinforcement-learning line.
Benchmarks reported
Every row is one pairing from the survey's relation file; a score belongs to the benchmark page's ranking, where it is shown with metric, eval set, source type and date. 0 of 1 pairings are counted.
| Benchmark | Relation | Eval set / protocol | Source type | Note and evidence |
|---|---|---|---|---|
| 19 PMO (Practical Molecular Optimization) | Cited as comparison only (not counted) | — | Third-party | The PMO paper used the prior-generation REINVENT as a baseline; REINVENT 4 itself reports no PMO score. †partly verified · evidence |
Other evaluations (outside the 44)
- Feature comparison with two similar tools (Comparison against baselines only) Self-reported: The paper gives a table of design modes and learning styles, not performance scores
Developers report: Developers report one open framework covering several molecule design modes, already used in production on internal projects.
Independent evidence: No independent evidence found. Public evaluations feature the previous generation's implementation; no independent evaluation of this version was found
Training data
Group in Figure 7: Public data only.
| Class | Value | Detail |
|---|---|---|
| a. Public databases | Yes | Priors were trained unsupervised on SMILES from public molecule libraries; the paper lists no library versions and the versions given by secondary compilations could not be confirmed in the original source |
| b. Private or licensed data | No | The paper discloses no internal data used to train the public priors; internal project use is application, not training data source |
| c. Own wet-lab data used for training | No | source |
| d. Wet lab used only for validation | No | source |
Wet-lab validation
None. The developers report no wet-lab validation.
Background
- Organization: The developer is a molecular-AI group inside a large pharmaceutical company's R&D organisation, based in Sweden with members in the UK and funded from internal R&D budget.
- Funding: Not disclosed
- Products and partnerships: The same group also maintains a retrosynthesis planning tool; this framework merges four previously separate tools and its code is in a public repository.
- Related models: Saturn, GenMol
Reading notes
- Its value lies in engineering maturity and production use, not in benchmark standing.
- REINVENT figures in public evaluations usually come from a third party's implementation of the previous generation and must not be read as this version's results.
- The paper compares with only two similar tools and only by feature table, a narrow scope.
- No public wet-lab data corresponds directly to this model.
Caveats
- The site's recorded first-release date was the journal paper date and is corrected to the first public version.
- Under this round's relation rules it enters the zero-pairing list: it has no countable pairing with any benchmark on this site.
- The versions of the public libraries behind the priors have no primary source, so second-hand version numbers should not be repeated.
Sources
- Journal paper (journal) · 2024-02-21
- Release list (repository)
- Code repository (repository)
- Third-party benchmark paper (preprint)
Corrections
2 corrections
| Field | Was | Now | Basis | Found |
|---|---|---|---|---|
| first_release | 2024-02-21 | 2023-11-07 (first public release v4.0.11) | source | 2026-11-16 |
| benchmarks_reported | Has results on this optimization benchmark (third-party) | Only the previous generation is used by third parties as a baseline; this version has no self-reported result, so the relation is changed to cited only and not counted | source | 2026-11-16 |
Part of the AI for Bio benchmarks survey · all 112 models · open in the explorer. Record as of 2026-11-16.